Company Profiles

driven by the PitchBook Platform

Liquidia Technologies

Description

Developer of a print technology designed to transform the development of new therapies by precisely engineering drug particles. The company's print technology with a modular, roll-to-roll manufacturing process creates precisely-constructed cavities enabling pharmaceutical companies to reduce manufacturing costs and complexity.

2004

Founded

PRIVATE

Status

51-200

Employees

Series D

Latest Deal Type

$18.4M

Latest Deal Amount

$82.3M

Total Amount Raised

Description

Developer of a print technology designed to transform the development of new therapies by precisely engineering drug particles. The company's print technology with a modular, roll-to-roll manufacturing process creates precisely-constructed cavities enabling pharmaceutical companies to reduce manufacturing costs and complexity.

Website:

www.liquidia.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

Post Office Box 110085 Research Triangle Park Durham, NC 27709United States +1 (919) 328-4400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Liquidia Technologies's full profile, request a free trial.

Liquidia Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Liquidia Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Liquidia Technologies Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bill & Melinda Gates FoundationNot-For-Profit Venture CapitalMinority000 0000000 0000
Canaan PartnersVenture CapitalMinority000 0000000 0000
Firelake Capital ManagementVenture CapitalMinority000 0000000 0000
GlaxoSmithKlineCorporationMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
Canaan Partners Venture Capital
Firelake Capital Management Venture Capital
GlaxoSmithKline Corporation
Individual Investor Angel (individual)

Liquidia Technologies Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Neal FowlerChief Executive Officer & Board Member
Timothy AlburyChief Financial Officer
Robert LippeChief Operations Officer
Jeff KindigDirector, Analytical
Michele StoneExecutive Director, Vaccines
Neal Fowler Chief Executive Officer & Board Member
Timothy Albury Chief Financial Officer
Robert Lippe Chief Operations Officer
Jeff Kindig Director, Analytical
Michele Stone Executive Director, Vaccines

Liquidia Technologies Board Members (11)

NameRepresentingRoleSinceContact
Info
Arthur KirschSelfBoard Member000 0000
Edward MathersNew Enterprise AssociatesPartner000 0000
Eric LinsleyPappas VenturesManaging Partner000 0000
Isaac Cheng MDMorningside GroupInvestor000 0000
Joseph DeSimone Ph.DSelfCo-Founder, Scientific Advisor & Board Member000 0000
Arthur Kirsch Board Member Self
Edward Mathers Partner New Enterprise Associates
Eric Linsley Managing Partner Pappas Ventures
Isaac Cheng MD Investor Morningside Group
Joseph DeSimone Ph.D Co-Founder, Scientific Advisor & Board Member Self
Request full access to PitchBook